Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUBY study: corticosteroid therapy versus placebo in fibrotic hypersensitivity pneumonitis
2025-521591-64-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypersensitivity pneumonitis (HP) comparing Prednisolone arm with Placebo arm (2 arms). Planned start Aug 2026; status: authorised.
02
Drugs
prednisolone
03
Conditions
hypersensitivity pneumonitis (HP)
Beyond the preview
Go deeper on 2025-521591-64-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521591-64-00.